Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when UHT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsUHT grants restricted stock to four executives, holds routine annual meeting
Filed June 11, 2026 · Period ending June 10, 2026 · ~1 min read
Key Changes
-
medium
Board granted restricted stock awards to four executives on June 10, 2026, vesting in two years with accumulated dividends paid only on vested shares. CEO Alan Miller received 6,247 shares, CFO Charles Boyle and SVP Cheryl Ramagano each received 3,631 shares, and VP Karla Peterson received 1,598 shares.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
low
Shareholders elected Alan B. Miller (97.6% support, 9,187,560 for vs. 222,081 against) and Robert F. McCadden (90.8% support, 8,540,716 for vs. 868,560 against) as Class I trustees for three-year terms expiring in 2029. Broker non-votes: 2,233,065.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR → -
low
Advisory say-on-pay vote passed with 95.6% support (8,955,099 for vs. 418,954 against), reflecting strong shareholder approval of executive compensation practices. Broker non-votes: 2,233,065.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR → -
low
Shareholders ratified KPMG, LLP as independent auditor for fiscal 2026 with 99.0% support (11,525,347 for vs. 114,360 against), confirming continuity in the audit relationship.
Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
Summary
Universal Health Realty Income Trust disclosed two routine corporate events: executive equity compensation and its annual meeting results. On June 10, 2026, the Board granted restricted stock awards to four executives as the Trust's primary long-term incentive. The shares vest after two years, with dividends accumulating during the vesting period and paid only on shares that ultimately vest.
The CEO received the largest grant at 6,247 shares, with other officers receiving amounts scaled to their roles. The annual meeting results were routine. Shareholders re-elected two trustees with strong support (97.6% and 90.8%), approved executive compensation with 95.6% support, and ratified the auditor with 99.0% support. All proposals passed with comfortable majorities typical of uncontested governance matters. The filing reflects normal course compensation and governance activity with no material concerns for investors.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
on June 10, 2026, the Compensation Committee of the Board of Trustees recommended, and the Board of Trustees granted, restricted stock awards to each of our executive officers. The restricted shares are scheduled to vest on the second anniversary date of the award. Dividends declared by us are accrued and accumulated with respect to these shares and will be paid in the aggregate on the vesting date on the shares that ultimately vest.
The Board granted restricted stock awards to four executive officers on June 10, 2026. The shares vest after two years, and dividends accumulate during the vesting period and are paid out only on shares that ultimately vest. This is the company's primary form of long-term incentive compensation for executives.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 13, 2026 · How we verify